Peptides are short chains of amino acids, the building blocks of proteins, linked together by peptide bonds. While proteins typically contain hundreds or thousands of amino acids, peptides usually consist of 2 to 50 amino acids.

In the human body, peptides act as signalling molecules that help regulate many biological processes. Depending on their structure and function, peptides may influence tissue repair, inflammation, immune responses, hormone signalling, cellular communication, and skin health.

Therapeutic peptides used in regenerative and longevity-focused medicine are designed to mimic or enhance naturally occurring biological processes. By interacting with specific receptors and pathways in the body, they may support healing, recovery, metabolic health, and healthy ageing when prescribed and used appropriately under medical supervision.

Not all peptides are created equal. The amino acid sequence is only one factor that determines the quality, safety, and effectiveness of a peptide product.

Important considerations include:

• Purity: High-purity peptides (typically ≥98–99%) help minimise unwanted by-products, truncated or incomplete peptide fragments, and contaminants that could affect safety and/or efficacy.
• Manufacturing Standards: Peptides should be manufactured in Good Manufacturing Practice (GMP)-compliant facilities with recognised quality control systems and rigorous testing procedures, including analytical verification techniques such as High-Performance Liquid Chromatography (HPLC) and mass spectrometry.
• Stability and Formulation: Appropriate manufacturing, storage, and handling practices are essential for maintaining peptide integrity. This includes proper lyophilisation and reconstitution methods, which are essential to maintain peptide bioactivity.
• Source and Traceability: Reputable suppliers should provide batch-specific documentation and quality records that allow full traceability of ingredients.
• Route of Administration: Different peptides may require different delivery methods, such as topical, oral, nasal, or subcutaneous administration, each requiring specialised formulation considerations.

Selecting products based solely on price, marketing claims or convenient and unregulated accessibility may increase the risk of poor-quality products, inconsistent results, or avoidable health risks.

Peptides act as highly specific biological signalling molecules or messengers. They interact with receptors on cell surfaces or within cells to initiate signalling pathways that influence physiological processes.

Depending on the peptide, these effects may include:

• Supporting tissue repair and regeneration
• Modulating inflammatory responses
• Stimulating collagen production and skin renewal
• Supporting hormone signalling pathways
• Influencing immune system activity
• Promoting cellular resilience and recovery
• Supporting blood vessel formation and tissue remodelling

As peptides often target specific biological pathways, they may offer a more targeted therapeutic approach than some conventional medications. However, their safety and effectiveness depend on appropriate product quality, patient selection, dosing, and medical supervision.

Peptides are currently being investigated and utilised across a range of medical, regenerative, and wellness-focused applications, including:

• Musculoskeletal recovery and rehabilitation
• Tendon, ligament, muscle, and joint support
• Skin health and aesthetic rejuvenation
• Wound healing and tissue repair
• Hair restoration and scalp health
• Metabolic health and body composition support
• Healthy ageing and longevity-focused interventions
• Gastrointestinal support and gut health
• Cognitive and neurological support (emerging areas of research)

Different peptides target different biological pathways. In some cases, healthcare practitioners may prescribe combinations of peptides to address multiple therapeutic goals simultaneously. Such approaches should always be undertaken under appropriate medical supervision.

At CeleRevive, we prioritise patient safety, quality assurance, scientific integrity and medical oversight in every aspect of our approach.

• Pharmaceutical-Grade Sourcing: We work exclusively with licensed pharmaceutical suppliers and compounding partners operating within South Africa’s regulatory framework. These licenced pharmaceutical suppliers include wholesale pharmacies that import Active Pharmaceutical Ingredients (APIs) from GMP-compliant manufacturers.
• Rigorous Quality Standards: Products are sourced, compounded, and tested in accordance with recognised quality assurance procedures and batch-specific documentation requirements. All peptide products are of ≥98–99%+ purity with full batch traceability.
• Medical Oversight: Prescription products are supplied only following consultation with a registered South African medical practitioner and where clinically appropriate.
• Licensed Compounding: Patient-specific formulations are prepared by licensed compounding pharmacies in accordance with applicable legislation and Good Pharmacy Practice (GPP) standards.
• Scientific Review: Our team includes qualified scientists and healthcare professionals who review product information, supporting documentation, and quality records.
• Patient Support: Our qualified medical practitioners provide guidance on product use, storage, administration, and ongoing monitoring where appropriate.

We believe regenerative and longevity-focused therapies should be approached responsibly through evidence-informed medicine, regulatory compliance, and personalised healthcare.

Patient safety remains our highest priority.

Products offered through CeleRevive are:

• Prescribed on an individual patient basis following consultation with a qualified medical practitioner
• Compounded and dispensed by a fully licensed and A-grade rated South African compounding pharmacy
• Subject to strict pharmacy quality assurance and compounding standards where applicable
• Supported by appropriate medical guidance and follow-up
• Supplied in accordance with applicable South African regulatory requirements

We do not encourage self-medication, unsupervised use, or the procurement of products through unregulated sources.

The growing popularity of peptides and wellness therapies has led to the emergence of numerous unregulated suppliers, online vendors, and products marketed as “research chemicals”, “for research use only”, or “not for human consumption”.

While these products may appear less expensive or easier to obtain, they can present significant risks to your health and safety.

Potential risks include:

• Unknown Purity, Potency, or Composition: Products may contain impurities, incorrect concentrations, undeclared ingredients, or substances that differ from those listed on the label.
• Contamination: Products may be contaminated with heavy metals, bacterial endotoxins, microorganisms, residual solvents, or other potentially harmful substances.
• Counterfeit or Mislabelled Products: The contents of the product may not match the packaging or advertised specifications, resulting in ineffective treatment or unexpected adverse effects.
• Lack of Sterility: Injectable products obtained from unregulated sources may not be manufactured under sterile conditions, increasing the risk of infection, inflammation, abscess formation, and other serious complications.
• Incorrect Dosing: Inaccurate formulation or poor manufacturing standards may result in underdosing, overdosing, or inconsistent dosing between batches.
• No Medical Oversight: Without assessment by a qualified healthcare professional, important contraindications, underlying medical conditions, drug interactions, or safety concerns may be overlooked.
• Legal and Regulatory Risks: Products obtained outside regulated healthcare channels may not comply with South African regulatory requirements and may bypass important quality and safety controls designed to protect patients.

The South African Health Products Regulatory Authority (SAHPRA) has repeatedly warned consumers about the risks associated with unregulated medicines, compounded products, and peptide therapies.

Your health is not worth the risk. For your safety, always obtain prescription products through licensed healthcare professionals, registered pharmacies, and regulated supply chains that maintain appropriate quality, safety, and professional oversight.

Many patients report improvements in areas such as recovery, wellbeing, body composition, skin health, sleep quality, and overall vitality when peptide-based therapies form part of a broader treatment strategy.

However, responses vary significantly between individuals.

Factors influencing outcomes may include:

• Age
• Medical history
• Genetics
• Nutrition
• Sleep quality
• Physical activity levels
• Stress management
• Concurrent treatments and medications

Peptides are not a substitute for comprehensive healthcare and should not be viewed as miracle cures. The best outcomes are typically achieved when they are integrated into a broader approach that includes appropriate medical care, lifestyle optimisation, nutrition, exercise, sleep, and stress management.

When sourced through regulated channels and used under appropriate medical supervision, many therapeutic peptides are generally well tolerated. However, as with any biologically active compound, side effects and risks may occur.

Potential side effects vary depending on the specific product and may include:

• Injection-site reactions
• Temporary redness or irritation
• Mild nausea
• Headache
• Fatigue
• Gastrointestinal symptoms

Certain products may not be appropriate for individuals who are pregnant, breastfeeding, undergoing treatment for active malignancy, or who have specific medical conditions.

A comprehensive medical assessment is essential before commencing any peptide or prescription wellness therapy. One of our CeleRevive healthcare practitioners will review your medical history, current medications, treatment goals, and potential risk factors to determine whether a particular therapy may be suitable for you.

In South Africa, medicines, therapeutic peptides, compounded pharmaceutical products, and certain health-related substances are regulated by the South African Health Products Regulatory Authority (SAHPRA) in accordance with the Medicines and Related Substances Act, 1965.

The products offered through CeleRevive fall into several regulatory categories, including registered medicines, compounded prescription medicines, wellness formulations, and investigational peptide products. The regulatory status of each product depends on the active ingredient, dosage form, route of administration, intended use, and whether a registered commercial equivalent exists in South Africa.

Certain active pharmaceutical ingredients available through CeleRevive have established regulatory recognition and accepted medical use in South Africa. These include medicines such as semaglutide, tirzepatide, testosterone cypionate, minoxidil, naltrexone, and methylcobalamin. While some of these ingredients may be available in registered commercial products, the formulations supplied may be compounded on a patient-specific basis by licensed compounding pharmacies where clinically appropriate.

CeleRevive also offers a range of compounded prescription medicines and wellness formulations containing recognised pharmaceutical, nutritional, hormonal, or biological ingredients. These products may include ingredients such as melatonin, NAD+, glutathione, vitamins, minerals, amino acid derivatives, and other wellness-focused compounds. Such products may not necessarily be registered in the specific dosage form, strength, route of administration, or indication for which they are prescribed and may therefore be used on an off-label basis at the discretion of the prescribing medical practitioner.

In addition, certain investigational or experimental peptide products offered through regulated compounding pathways may not be registered by SAHPRA for the indications described. These products may include peptides such as BPC-157, TB-500, AOD-9604, MOTS-c, SS-31 (Elamipretide), CJC-1295, Ipamorelin, Selank, Semax, DSIP, Cagrilintide, and other investigational peptide formulations or combinations. Such products are generally considered investigational, experimental, or off-label in nature and are supplied only following assessment by a registered medical practitioner and the issuance of a valid prescription.

Licensed pharmaceutical wholesalers may import active pharmaceutical ingredients (APIs) under the appropriate SAHPRA permits and regulatory approvals. Licensed compounding pharmacies may then prepare patient-specific formulations in accordance with applicable legislation, including Section 14(4) of the Medicines and Related Substances Act and Good Pharmacy Practice (GPP) standards.

Depending on the specific product, indication, and regulatory requirements applicable at the time of prescribing, additional regulatory authorisations, including SAHPRA Section 21 approval, may be required. The prescribing medical practitioner is responsible for determining the clinical appropriateness of a product, while pharmacies remain responsible for compliant sourcing, storage, compounding, dispensing, quality assurance, and maintenance of product integrity.

SAHPRA has repeatedly cautioned against the use of unregulated pharmaceutical and peptide products due to concerns relating to product quality, contamination, mislabelling, counterfeit products, and illegally imported substances. These warnings highlight the importance of obtaining medicines and therapeutic products only through legitimate, regulated channels.

At CeleRevive, we work exclusively with licensed pharmaceutical suppliers, accredited compounding pharmacies, qualified scientists, and registered medical practitioners to maintain the highest standards of product quality, patient safety, regulatory compliance, and professional oversight.

Below is a summary of the current regulatory classification of products available through CeleRevive as of June 2026.

Category 1: Registered and Established Medicines

These medicines contain active pharmaceutical ingredients with established regulatory recognition and accepted medical use in South Africa. While some active ingredients may be available in registered commercial products, the formulations supplied may be compounded on a patient-specific basis by licensed compounding pharmacies. Such products are prescribed by registered medical practitioners where clinically appropriate and in accordance with applicable regulatory requirements.

• Semaglutide
• Tirzepatide
• Testosterone Cypionate
• Minoxidil (all strengths)
• Low-Dose Naltrexone (active ingredient is a registered medicine, although compounded LDN is typically prescribed off-label)
• Methylcobalamin (Vitamin B12 injectable)

Category 2: Compounded Prescription Medicines and Wellness Formulations

Compounded prescription formulations containing recognised pharmaceutical, nutritional, hormonal, or biological ingredients. These products are prescribed on an individual patient basis and may be used outside registered indications. They may not necessarily be registered in the specific dosage form, route of administration, strength, or indication offered.

• Berberine
• Curcumin
• Omega-3
• NAC (N-Acetyl-L-Cysteine)
• L-Glutathione Capsules
• L-Glutathione Pen
• L-Carnosine
• Alpha GPC
• Ashwagandha
• 5-HTP
• Melatonin (all formulations and strengths)
• Vitamin D3 (all strengths)
• Vitamin K2 (all strengths)
• Magnesium L-Threonate
• Magnesium Glycinate + Vitamin D3 + Vitamin K2
• B-NAD+ Nasal Spray
• B-NAD+ Pen
• B-NAD+ Pen Refill
• PT-141 (Bremelanotide) Nasal Spray
• PT-141 (Bremelanotide) Pen
• Tesamorelin

Category 3: Investigational / Experimental Peptide Products and Combination Formulations

Investigational peptide formulations supplied on a prescription-only, patient-specific basis through licensed compounding pharmacies. These products are not registered by SAHPRA for the indications described and are generally considered experimental, investigational, or off-label in nature.

Individual Peptides

• AOD-9604
• MOTS-c
• SS-31 (Elamipretide)
• BPC-157
• TB-500
• GHK-Cu
• CJC-1295 (with DAC)
• CJC-1295 (without DAC)
• Ipamorelin
• Selank
• Semax
• DSIP (Delta Sleep-Inducing Peptide)
• Cagrilintide

Combination Peptide Formulations

• MOTS-c + SS-31
• BPC-157 + TB-500
• BPC-157 + TB-500 + GHK-Cu
• CJC-1295 + Ipamorelin
• Tirzepatide + Cagrilintide
• Semaglutide + Tirzepatide combinations